BCAB
BioAtla, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
BioAtla (BCAB) Stock: Buy, Sell, or Hold?
$1.74
-1.41 (-44.75%)
▼
5d:
-45.44%
30d:
-48.67%
90d:
-55.85%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (40%)
Quality Score
39/100
Position
FAIR
Forward P/E & Valuation
-1.3x
Next 12M consensus est.
Wall Street Target
$10.00
+476.4% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$1.51 / $4.00
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: BCAB is down 45.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When BCAB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: BCAB is currently trading at $1.74, which is considered fair based on recent price action.
Technical Outlook: Technically, BCAB is in a downtrend. Immediate support is located at $1.51, while resistance sits at $4.00. Short-term momentum is weak, with the stock down 44.7% recently.
Market Sentiment: BCAB scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.00 (+476.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BCAB is in a downtrend. Immediate support is located at $1.51, while resistance sits at $4.00. Short-term momentum is weak, with the stock down 44.7% recently.
Market Sentiment: BCAB scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.00 (+476.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
39/100
(SELL)
Volume Confirmation
UNKNOWN
Confidence Score
39.5%
Trading Range & Key Levels
Support Level
$1.51
Resistance Level
$4.00
Current Trend
Downtrend
Technical data as of
Aug 28, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BEARISH: Downward momentum (-44.7%)
- BULLISH: Trading 476.4% below Wall St target ($10.00)
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.30
Wall Street Target
$10.00
(+476.4%)
Revenue Growth (YoY)
31.6%
Share BCAB Analysis
Share this live BCAB analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (BCAB)
Bearish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Aug 17, 2026
Daily AI digest
AI Retail Discussion Summary:
A bearish StockTwits message warns that $BCAB may be delisted due to a lack of funds. No recent news articles were available.
Key Retail Themes:
financial instability
delisting risk
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:28 AM ET
Data refreshes hourly during market hours. Next update: 10:28 AM
Data refreshes hourly during market hours. Next update: 10:28 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BCAB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeOne Medicines AG |
STRONG BUY
27 analysts |
$438 | 40 SELL |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$302 | 49 HOLD |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
15 analysts |
$22 | 72 BUY |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$75 | 66 BUY |
|
KURA
Kura Oncology Inc |
STRONG BUY
16 analysts |
$32 | 60 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive BCAB Research Pages
